Salarius Pharmaceuticals, Inc.·4

Jan 5, 5:44 PM ET

McVicar William K. 4

4 · Salarius Pharmaceuticals, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
McVicar William K.
President, R&D
Transactions
  • Award

    Common Stock

    2023-01-03+1,4401,788 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,062
Footnotes (1)
  • [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024

Documents

2 files